Furientis's $250K Missile Just Got $25M From Benchmark — and a 15x Cost Gap the Primes Can't Ignore

On October 6, 2026, Furientis announced two things in tandem — a $25M seed round led by Benchmark, with general partner Chetan Puttagunta joining the board, and its first funded government contract, a prototyping OTA from the Department of War for a 100-mile-range interceptor aimed at homeland defense. The pairing signals that low-cost interceptor economics are now both fundable and investable, because each announcement ratifies the thesis the other depends on.

The valuation is $125M post-money, per a person familiar with the round. Furientis previously announced a $5M pre-seed in May 2026 led by Silent Ventures, with Bessemer Venture Partners, SV Angel, Vanderbilt University, Channel 39 Ventures, and founders of Anduril and Armada participating. Co-founders Brody Franzen (formerly of Virgin Galactic and Castelion) and Aris Simsarian (formerly of Virgin Orbit) had already run ten static firings of their rocket motor and six flight tests of the interceptor demonstrator by the time the seed closed.

Furientis is targeting roughly $250,000 per interceptor. Against that number, the legacy stack looks like a different industry. Patriot PAC-3 MSE runs about $3.7 million per round; Standard Missile 6 runs $4-9.6 million; SM-3 Block IB sits at $10-15 million; SM-3 Block IIA runs $27.9 million; THAAD runs $11-15 million. The cost gap is 15x on the cheap end and 60x on the expensive end — and that ratio is the whole reason the disruption thesis is more than a pitch deck.

The U.S. Navy currently takes delivery of roughly 300-500 shipborne interceptors per year, per the company's framing. China has claimed production capacity of roughly 3,000 anti-ship cruise missiles per month — an order-of-magnitude production gap that is the reason the cost gap matters at all. When the offense outspends the defense on units, the defense needs cheaper units.

The Pentagon's fiscal 2027 budget request makes the gap visible in dollar terms. Missile-related procurement jumps 188% over fiscal 2026 — a $24.5B FY26 baseline climbing toward ~$70.5B in FY27, with about $40B of the munitions request funded through reconciliation. PAC-3 MSE buy jumps from 357 rounds (FY26 Army) to 3,203 rounds in FY27 — a near-9x increase. THAAD interceptors funded go from 55 in FY26 to 857 in FY27. Standard Missiles increase from 166 to 540. The budget is no longer pretending the gap is hypothetical.

Benchmark's investment is its first pure defense bet. The dollar figure ($25M against Lockheed Martin's $46.6B MFC backlog) is rounding error. What matters is the signal: a generalist VC that took down eBay, Twitter, Uber, and Meta putting a partner on a defense startup's board marks the moment low-cost interceptors crossed from hunter-gatherer to investable.

The funding backdrop confirms the read. $35.6B went into defense and defense-adjacent startups in the first half of 2026 — already more than full-year 2025 totals. Anduril sits at $61B post-money after a $5B Series H. Castelion, a hypersonic peer, raised $1B at $13B in August. Cambridge Aerospace hit $3.4B on $300M. Saronic, a naval-autonomy peer, raised $1.75B at $9.25B. Furientis at $125M post-money is the smallest number on the leaderboard, and the only one priced as a pure interceptor seed — which is the part Benchmark is underwriting.

The disruptor story ignores an inconvenient number: the primes are scaling too, and they have the budget locked in. Lockheed Martin's Missiles and Fire Control segment posted 2025 sales of $14.45B (vs $12.68B in 2024) with segment backlog of $46.65B at year-end. Total company backlog was a record $193.6B. PAC-3 MSE output is going from approximately 600/year to 2,000/year under a seven-year framework agreement — the same program Boeing just received a $14.7B undefinitized contract to triple seeker production for.

Near-term (days to quarters): the primes win. Multi-year framework deals, the 188% missile budget bump, and tripling production capacity are locked in for fiscal 2027-2030. Furientis has one OTA and one $25M seed; Lockheed Martin, RTX, Northrop Grumman, General Dynamics, and L3Harris collectively hold more than $200B of missile-defense backlog. The disruption thesis needs Furientis — or Castelion, or Anduril's Roadrunner-M — to demonstrate kill-chain performance before any incumbent revenue line is at risk.

Long-term (1-3 years): the disruption thesis is the bet to make. If Furientis' 100-mile-range demonstrator clears testing and reaches a fielded configuration at $250K, the next PAC-3 ACE cycle (which Lockheed Martin is already positioning as a cheaper variant) and the next-generation THAAD/SM-3 procurement face a fundamental pricing question. Northrop Grumman's THAAD economics at $11-15M per round are the most exposed if a $250K-class alternative reaches similar exo-atmospheric capability.